TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00036920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: canfosfamide hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]